STUDIES ON THE PHARMACOKINETICS OF CHLORAMBUCIL AND PREDNIMUSTINE IN PATIENTS USING A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY
STUDIES ON THE PHARMACOKINETICS OF CHLORAMBUCIL AND PREDNIMUSTINE IN PATIENTS USING A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY
复制标题
DOI:
10.1007/bf00451643
复制
发表时间:
1989-01-01
影响因子:
3
通讯作者:
MUHLENBRUCH, B
中科院分区:
文献类型:
--
作者:
OPPITZ, MM;MUSCH, E;MUHLENBRUCH, B
Following the oral administration of either chlorambucil/prednisolone or prednimustine to patients, the plasma levels of free chlorambucil and phenylacetic acid mustard, the .beta.-oxidation product of chlorambucil, were measured using a new high-performance liquid chromatographic (HPLC) assay. This assay permitted the simultaneous detection of the analyzed compounds with a lower limit of detection of 30 ng/ml. The pharmacokinetics of chlorambucil and phenylacetic acid mustard were found to be entirely different when prednimustine was administered as opposed to its components chlorambucil and prednislone together. After the ingestion of the conjugate, the plasma concentration-time curves of chlorambucil and phenylacetic acid mustard showed a "delayed" pattern compared with those obtained after the administration of the components. The mean area under under the concentration-time curves (AUCs) of prednimustine-derived chlorambucil and phenylacetic acid mustard were 25% and 40%, respectively, of the areas obtained after a stoichiometrically equivalent dose of chlorambucil Free plasma prednimustine could not be detected at any time. This different pharmacokinetic behavior might offer an explanation for the superior therapeutic effects prednimustine demonstrated by clinical studies.